Asthma is a disease that can often become tricky to manage. However, managing asthma and pregnancy is an even more complex task.
Asthma is a disease that can often become tricky to manage. However, managing asthma and pregnancy is an even more complex task.
When Fiona Feltrin fell pregnant with twins, her asthma treatment soon became a priority.
“Originally there was a lot of fear about the impacts that asthma medication had on babies,” Fiona said, “I used to worry about which treatments would be safe during my pregnancy.”
Fiona soon enrolled in the Managing Asthma in Pregnancy (MAP) Study, conducted by Professor Peter Gibson and Kelly Steel.
Traditionally the symptoms of Fiona’s asthma were treated by her GP, however the MAP Study offered a much more expansive analysis of both her asthma and her pregnancy.
“Participating in the study was so much more effective because every aspect of your asthma was analysed and it was a very powerful motivator to see where your health was sitting,” Fiona said.
The study not only monitored my asthma during my pregnancy with the twins it motivated me to take better care of my asthma rather than simply treating the symptoms.”
The MAP Study monitored a range of aspects of asthma including Fiona’s lung function, blood, and sputum and nitrous oxide.
“This is a very important study, firstly for pregnant women with asthma, and secondly for people with asthma in general,” Professor Gibson said.
“For women with asthma who are pregnant, we now have a way that can very significantly reduce asthma attacks, and this appears to benefit not only the mothers but also their babies.”
Not only did the MAP Study enable Fiona to breathe a little easier knowing her asthma was being watched closely, it also gave her the chance to update her knowledge on asthma and review her treatment.
“It allowed me to make good habits for my health again. I was reminded of things I should be incorporating back into my lifestyle.”
Fiona now has two healthy twins and feels that the MAP Study had a positive long term impact on her health.
“Nine months of monitoring really allowed me to watch what was happening with my asthma and engage in the process of trying to improve it,” she said.
“Now I am more engaged with my health and what needs to be done.”
HMRI would like to acknowledge the Traditional Custodians of the land on which we work and live, the Awabakal and Worimi peoples, and pay our respects to Elders past and present. We recognise and respect their cultural heritage and beliefs and their continued connection to their land.
Hunter Medical Research Institute
We’re taking healthy further.
Locked Bag 1000
New Lambton
NSW, Australia, 2305
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 Hunter Medical Research Institute | ABN: 27 081 436 919
Site by Marlin Communications